---

Back one screen: left arrow Back to main menu: ESC CALCIUM CHANNEL BLOCKERS : TOXICITY Adverse Reactions and Overdose Toxicity: * CV: Peripheral edema (especially with nifedipine), hypoten- sion, bradycardia (rare with nifedipine), congestive heart failure. Overdosage can produce marked hypotension and bradycardia (especially verapamil) and/or conduction block. * CNS: Dizziness and headache (especially nifedipine), sleep disturbances, blurred vision. * GI and metabolic: Nausea (especially nifedipine), constipation (especially verapamil). Exacerbation of noninsulin-dependent (Type II) diabetes has been reported. * Treatment of overdosage: Sympathomimetics and a transvenous pacemaker may be needed. Parenteral calcium may be tried cau- tiously. (PgDn key for more text) Interactions * CV Depressants: Additive effects on cardiac contractility, automaticity and AV conduction. * Pharmacokinetic: Verapamil and possibly nifedipine may in- crease digoxin blood levels, but the clinical significance of the effect is minimal. References: 1. Johnson SM et al: A controlled trial of verapamil for Prinzmetal's variant angina. N Engl J Med 1981; 304: 862. 2. Lindenberg BS et al: Efficacy and safety of incremental doses of diltiazem for the treatment of stable angina pectoris. J Am Coll Cardiol 1983; 2:1129. 3. McAllister RG, Hamann SR, Blouin RA: Pharmacokinetics of calcium-entry blockers. Am J Cardiol 1985; 55:30B. 4. Muller JE et al: Nifedipine and conventional therapy for un- stable angina pectoris: a randomized, double-blind com- parison. Circulation 1984; 69: 728. 5. Weiner DA et al: Efficacy and safety of verapamil in patients with angina pectoris after 1 year of continuous, high-dose therapy. Am J Cardiol 1983; 51:1251. (Home to return to top of file)

---

The views and opinions stated within this web page are those of the author or authors which wrote them and may not reflect the views and opinions of the ISP or account user which hosts the web page. The opinions may or may not be those of the Chairman of The Skeptic Tank.

Return to The Skeptic Tank's main Index page.

E-Mail Fredric L. Rice / The Skeptic Tank